About 50 results
Open links in new tab
  1. Latest Medical News, Clinical Trials, Guidelines - Medscape

    Jan 16, 2026 · Today on Medscape : Get the latest medical news, clinical trial coverage, drug updates, journal articles, CME activities & more on Medscape. A free resource for physicians.

  2. DDW 2025 - Medscape

    May 19, 2025 · Digestive Disease Week (DDW) 2025 : Read clinically focused news coverage of key developments from DDW 2025

  3. ASH 2025: Key Highlights in Follicular Lymphoma - Medscape

    Dr Kami Maddocks reports on epcoritamab plus R2, as well as long term bispecific and CAR T data, in follicular lymphoma.

  4. Why Compounded Semaglutide and Tirzepatide Is Risky - Medscape

    Jan 21, 2025 · Dr Priya Jaisinghani discusses compounded semaglutide and tirzepatide.

  5. Beyond Triple Therapy: Next Steps for Resistant Hypertension

    Jan 2, 2026 · Thelma’s blood pressure remains high despite triple therapy. Dr Vega applies the 2025 ACC/AHA guidelines to determine the best next step for his patient.

  6. Lancet Experts Flag Global Ultraprocessed Food Threat - Medscape

    A new three-paper Lancet Series links rising ultraprocessed food intake to worsening diet quality and a higher risk for multiple chronic diseases worldwide.

  7. Inside Epic’s Rapid-Fire Research Machine - Medscape

    Nov 6, 2025 · Epic Research is rewriting the rules of medical publishing by using massive patient datasets to deliver fast, accessible studies outside traditional journals.

  8. Investigate Shortness of Breath: Here’s How - Medscape

    Jul 28, 2025 · Primary care physicians are often the first stop for patients with symptoms of shortness of breath. Here’s what to look for.

  9. Diagnosis & Management of Exocrine Pancreatic Insufficiency

    Diagnosing exocrine pancreatic insufficiency can be vexing to clinicians, but missing it may deprive patients of access to effective, lifesaving therapies, according to Dr David Whitcomb.

  10. Two-Drug Combo Promising for Methamphetamine Use Disorder

    Jun 27, 2024 · Extended-release formulations of an injectable naltrexone and oral bupropion were associated with significant decreases in methamphetamine use, a new study showed.